Dimitrios Kouvelas, PhD, has replaced Aikaterini Moraiti, PhD
Dimitrios Kouvelas, PhD, has replaced Aikaterini Moraiti, PhD, as Greece’s new member of the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency.
Kouvelas is a professor of pharmacology and clinical pharmacology at the Aristotle School of Medicine, University of Thessaloniki, and a visiting professor of pharmacology and clinical pharmacology, University Svetozar Markovic Medical Faculty, Kraguijevac, Serbia. His research fields include neuro/psychopharmacology, neuro-transmission, clinical pharmacology and rational prescribing.
Moraiti has been a member of the CHMP since 2012, and is a scientific expert for Greece’s National Organization of Medicines and a member of the Greek Committee for Orphan Medicines.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
FDA Fast Tracks Johnson & Johnson’s Nipocalimab for Fetal Neonatal Alloimmune Thrombocytopenia
March 27th 2024Johnson & Johnson is moving forward with a pair of Phase III trials of nipocalimab to reduce the risk of fetal neonatal alloimmune thrombocytopenia in alloimmunized pregnant patients.